Pfizer stock slips into holiday week as CEO filing, vaccine-policy row and biotech IPO news land
Shares of Pfizer Inc closed Friday down 0.9% at $25.65. Investors wrestled with a jumble of policy updates, regulatory filings, and a biotech IPO that dragged Pfizer’s name back into the paperwork spotlight.
